AI model links tumor mutations to treatment response

Researchers at University of California San Diego have developed a new artificial intelligence (AI) model that can translate a tumor's complex genetic profile into predictions about how that cancer may respond to treatment. The model, called MutationProjector, was trained on genomic data from more than 30,000 tumors across 10 solid cancer types and offers a new framework for connecting cancer mutations to the biological pathways that drive treatment response.